IMRT linked with low rates of pelvic recurrence in bladder cancer

Delivering intensity-modulated radiotherapy to the bladder and pelvic nodes in patients with node-positive bladder cancer or high-risk node-negative bladder cancer is feasible with patients experiencing low toxicity and demonstrating low pelvic nodal rates of recurrence, researchers reported at the 2017 Global Congress on Bladder Cancer.